Product Images Sutent

This is a comparison between SUTENT and Placebo in a trial involving 207 and 105 people respectively. SUTENT showed a median of 273 weeks, while Placebo had a median of only 6.4 weeks. The Hazard Ratio was 0.33, with a 95% confidence interval of 0.23 to 0.47, and p-value less than 0.0001. A Time to Tumor Progression Probabilty graph is also included.*

This is a statistical comparison of the median time in weeks that it took for the treatment with SUTENT and IFN-c to achieve 100% disease progression in 375 subjects each. SUTENT had a significantly longer median time of 47.3 weeks compared to IFN-c, which had a median time of 22.0 weeks. The hazard ratio for SUTENT compared to IFN-c was 0.42 with a 95% confidence interval between 0.32 and 0.54. The probability of these results occurring by chance was very low with a p-value less than 0.000001. The number of subjects at each time point is provided in a graph.*

This text describes the median years of disease-free survival for two groups of subjects, SUTENT (N=309) and PLACEBO (N=306). The disease-free survival probability is presented as a graph with hazard ratios and confidence intervals. The number of subjects at risk in each group over time is also shown.*

SUTENT has a higher probability of Progression Free Survival than Placebo, with a median of 10.2 months compared to 5.4 months respectively. The Hazard Ratio is 0.427 with 95% Confidence Interval ranging from 0.271 to 0.673. The statistical significance of the difference in survival was achieved with p=0.00018. The graph shows a higher percentage of subjects under SUTENT remaining free of progression over time.*

This text is a description of the distributor of a product, which is Pfizer Labs. It indicates that the company distributing the product is a division of Pfizer Inc and is located in New York with the zip code 10017.*

This is a description of a company called Pfizer Labs which is a division of Pfizer Inc, located in New York, USA. The text indicates that this company is involved in distribution of products, but does not provide any specific details about what type of products are distributed.*

This is a prescription medication called Sutent, which comes in the form of capsules. Each capsule contains 50 mg of sunitinib, which is equivalent to 66.8 mg of sunitinib malate. The medication should be stored at 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). The medicine should be dispensed in tight containers. The dosage and use information should be referred to in the accompanying prescribing information. This is a professional sample and not for sale. It is manufactured in Singapore and distributed by Pfizer Inc, NY, NY 10017, with a lot number and expiration date listed.*

This is a medication called Sutent, which comes in the form of capsules. Each capsule contains 12.5mg of sunitinib, which is equivalent to 16.7mg of sunitinib malate. It is available only with a prescription. The recommended storage temperature is between 20°C to 25°C with permitted excursions between 15°C to 30°C. It must be dispensed in a tightly sealed container. The dosage and usage instructions must be provided by the prescribing physician. This professional sample is not for sale and must always be dispensed with a medication guide. The manufacturer is Pfizer Inc, NY, NY 10017, and it is distributed by U.S. Pharmaceuticals. The LOT/EXP number is not available.*